EGFR and cancer: The epidermal growth factor receptors (EGFRs), a family of receptor tyrosine kinases (RTKs), are the most extensively studied drug targets for many tumors as they are aberrantly expressed in cancer cells and are actively involved in cell proliferation and differentiation [1,2].